- Cognition normally declines with age; however, the drop is steeper in the years after a heart attack, according to an analysis of data from six long-term studies of more than 31,000 adults in the U.S.
- The results suggest that proactively taking steps to prevent a heart attack may also be good for maintaining memory and executive functioning.
Embargoed until 4 a.m. CT/5 a.m. ET Thursday, Feb. 3, 2022
This news release contains updated information not in the abstract.
(NewMediaWire) – February 03, 2022 – NEW ORLEANS – Preventing heart attacks may help slow cognitive decline, according to preliminary research to be presented at the American Stroke Association’s International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans, and virtually, Feb. 8-11, 2022.
“We need to realize that what’s going on in the heart and brain are related. Managing risk factors to prevent a heart attack is actually good for your brain as well,” said Michelle C. Johansen, M.D., Ph.D., lead author of the study, an assistant professor of cerebrovascular neurology at the Johns Hopkins University School of Medicine and associate faculty in the Welch Center of the Bloomberg School of Public Health at Johns Hopkins, both in Baltimore. “We have shown that having a heart attack can be detrimental to your brain health over time.”
The study is among the first to examine both the short- and long-term impact of a sudden cardiac event on mental cognitive abilities. Researchers analyzed data in six long-term studies conducted between 1971 and 2017: Atherosclerosis Risk in Communities Study; Coronary Artery Risk Development in Young Adults Study; Cardiovascular Health Study; Framingham Offspring Study; Multi-Ethnic Study of Atherosclerosis; and Northern Manhattan Study. Of the 31,377 study participants: 56% were women, 23% were Black adults, 8% were Hispanic adults and 69% were white adults. Participants were a median age of 60 years the time of the first cognitive assessment.
To be included in the study, participants could not have had a heart attack or have been diagnosed with dementia. Because the studies used different cognitive measures and tested participants at different time intervals, a team of neuroscientists and statisticians “harmonized” the data prior to this analysis to adjust for differences among the study groups and the cognitive measure screening methods.
Cognitive tests were categorized into three areas: memory (such as the ability to memorize something initially and to later recall or recognize what you memorized); executive functioning (such as the ability to pay attention, plan, organize and make complex decisions) and global cognition (overall performance on cognitive tests, which includes both memory and executive functioning). Results were adjusted for numerous demographic factors, heart disease risk factors and cognitive test results prior to a heart attack. Participants who had a stroke during the follow-up period were no longer included in the analysis since stroke can impact cognition.
During the time participants were followed (between 4.9 to 19.7 years, with a median of 6.4 years), 1,047 had a heart attack. Researchers found that, compared with those who did not experience a heart attack, participants who had a heart attack:
- did not have a significant decline in any measure of cognition soon after the time of the heart attack when accounting for demographics and vascular risk factors; but
- did have significantly faster declines in memory, executive functioning and global cognition in the years following the heart attack.
“Dementia is a slow, step-wise process. One doesn’t wake up out of the blue with dementia. If a heart attack is a factor in the development of dementia, you would not anticipate that after adjusting for how sick a patient is that there would be cognitive decline immediately, however, we did find the significant change occurs several years later,” Johansen said. “It’s important to know that cognitive decline is a possibility after a heart attack, so physicians are both managing patients’ heart disease and looking for signs of dementia following a heart attack. It can even be a great conversation-starter about why it’s important for patients to follow medical advice to prevent a heart attack.”
Documenting the association between heart attack and cognitive decline opens the door to future research to identify the mechanisms that are involved. The researchers noted several mechanisms may be attributed to this link, such as ongoing damage to the brain from silent strokes, which is a stroke not large enough to be recognized as a stroke yet still impairing the supply of blood or oxygen to the brain; shared risk factors for heart attack and dementia (smoking and high blood pressure); or having a heart attack could change the structure of the heart and increase the risk of mini-clots going to the brain and reducing oxygen reaching the brain.
“For too long, we have thought about and addressed heart disease and brain disease as two separate conditions, and based on our study’s findings and other research, I don’t think we’re going to be able to keep doing that as we learn more,” Johansen said.
Although the study documented an association between heart attack and faster cognitive decline, it is unable to establish that a heart attack directly causes cognitive decline. Because the studies all took place in the United States, the results are likely to be generalizable to people in countries with similar medical resources. However, the findings may not be generalizable to people in countries where there is less access to medical care.
“The impact of a heart attack on cognitive function may turn out to be worse in places that don’t have access to things like blood pressure medications and statins to control disease after a heart attack. We don’t know, yet it is definitely something to think about, and it emphasizes the importance of preventing and treating heart attack worldwide, not simply in the United States,” Johansen said.
According to the American Heart Association, approximately every 40 seconds, someone in the U.S. will have a heart attack. Vascular disease risk factors, and particularly risk factors present in midlife, are associated with cognitive impairment, with a risk of dementia overall, and Alzheimer’s disease.
The American Heart Association is working to better understand the connection between cardiovascular health and brain health with leading supporters of brain health research including the Paul G. Allen Institute and Bill Gates. “While bridging vascular and brain science through innovative research will help scientists shed new light on the many causes or contributors to cognitive impairment and dementia, including Alzheimer’s disease, lifestyle behaviors remain an important target for preventing vascular dementia,” according to American Stroke Association volunteer expert, Karen L. Furie, M.D., M.P.H. who is chair of the department of neurology at Brown University’s Warren Alpert Medical School and chief of neurology at Rhode Island Hospital, The Miriam Hospital, and The Bradley Hospital in Providence, Rhode Island.
“Some cognitive decline is expected as we age, yet, as we learn more about how our brains change with age, we’re finding the same risk factors that impact heart health may also affect brain health. Controlling those risk factors needs to become an early and lifelong commitment, because it’s your blood pressure measures when you’re in early to mid-life -30s, 40s and 50s – that affects dementia or heart disease, rather than your measures in late adulthood,” Furie said.
Co-authors are: Wen Ye, Ph.D.; Alden Gross, Ph.D.; Rebecca F. Gottesman, M.D., Ph.D.; Dehua Han, M.P.H.; Nicholas Tilton, Ph.D.; Rachael Whitney, Ph.D.; Emily M. Briceño, Ph.D.; Bruno J. Giordani, Ph.D.; Supriya Shore, M.D., M.S.; Mitchell S. V. Elkind, M.D., M.S.; Jennifer J. Manly, Ph.D.; Ralph L. Sacco, M.D., M.S.; Michael Griswold, Ph.D.; Bruce Psaty, M.D., Ph.D.; Stephen Sidney, M.D., M.P.H.; Jeremy B. Sussman, M.D., M.S.; Kristine Yaffe, M.D.; Andrew E. Moran, M.D., M.P.H.; Susan R. Heckbert, M.D., Ph.D.; Timothy M. Hughes, Ph.D.; Andrzej Galecki, M.D., Ph.D.; and Deborah A. Levine, M.D., M.P.H.
The study was funded by the National Institute of Neurological Disorders and Stroke and the National Institute of Aging of the National Institutes of Health. The list of authors’ disclosures is available in the abstract.
Statements and conclusions of studies that are presented at the American Stroke Association and American Heart Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. Abstracts presented at the Association’s scientific meetings are not peer-reviewed, rather, they are curated by independent review panels and are considered based on the potential to add to the diversity of scientific issues and views discussed at the meeting. The findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.
The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.
The American Stroke Association’s International Stroke Conference (ISC) is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. ISC 2022 will be held in person in New Orleans and virtually, Feb. 8-11, 2022. The three-day conference will feature more than 1,500 compelling presentations in 17 categories that emphasize basic, clinical and translational sciences as research evolves toward a better understanding of stroke pathophysiology with the goal of developing more effective therapies. Engage in the International Stroke Conference on social media via #ISC22.
About the American Stroke Association
The American Stroke Association is devoted to saving people from stroke — the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association officially launched in 1998 as a division of the American Heart Association. Connect with us on stroke.org, Facebook, Twitter or by calling 1-888-4STROKE.
For Media Inquiries and AHA Expert Perspective:
AHA Communications & Media Relations in Dallas: 214-706-1173; email@example.com
Karen Astle: 214-706-1392; firstname.lastname@example.org
For Public Inquiries: 1-800-AHA-USA1 (242-8721)
heart.org and stroke.org